Return to homepagePandemic Pact

ANTICOV: Preparation of an open-label, randomised, comparative, adaptive, multi-country study to test the safety and efficacy of new therapeutic strategies against standard of care in mild SARS-CoV-2 patients in resource-constrained settings

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:0 publications

Grant number: RIA2020EF-2975

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $220,000

  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)

  • Principal Investigator

    Dr. Nathalie Strub-Wourgaft

  • Research Location

    Switzerland

  • Lead Research Institution

    Drugs for Neglected Diseases initiative (DNDi)

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Phase 3 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract